SOPHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
SOPHARMA
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€14.3m
2024 · €965,281+€13.3m
Equity
€167.3m
2024 · €53.5m+€113.8m
Cash
€836,424
2024 · €271,914+€564,510
Balance sheet total
€172.1m
2024 · €54.3m+€117.8m
Largest movements
Assets
- Financial fixed assets +€82.9m
up €82.9m (+169%), from €49.1m to €132.0m
- Current investments +€31.6m
up €31.6m (+6,193%), from €510,561 to €32.1m
- Receivables within one year +€2.9m
up €2.9m (+207%), from €1.4m to €4.3m
of which Other amounts receivable: +€2.9m
Equity and liabilities
- Reserves +€77.6m
up €77.6m (+221%), from €35.1m to €112.7m
of which Distributable reserves: +€76.9m
- Contributions +€36.2m
up €36.2m (+219%), from €16.6m to €52.8m
- Other debts +€2.1m
up €2.1m (+1,608%), from €129,727 to €2.2m
Income statement
- Financial income +€14.9m
up €14.9m (+1,457%), from €1.0m to €15.9m
of which Financial income: +€13.9m
- Financial charges +€1.2m
up €1.2m (+5,789%), from €20,857 to €1.2m
of which Financial charges: +€770,004
- Gross operating margin -€211,915
down €211,915 (-65.2%), from €324,951 to €113,036
- Taxes +€88,138
up €88,138 (+91.0%), from €96,837 to €184,975
- Other operating charges +€41,385
up €41,385 (+2,314%), from €1,788 to €43,174
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€965,281
Gross operating margin
-€211,915
Staff costs
+€27,747
Depreciation
-€6,288
Other operating charges
-€41,385
Financial income
+€14.9m
Financial charges
-€1.2m
Taxes
-€88,138
Result 2025
€14.3m
raises the resultlowers the result
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€13.8m
Investment
-€114.5m
Financing
+€101.3m
Cash 2024
€271,914
From operations (derived)
+€13.8m
Net result for the year
+€14.3m
Depreciation
+€120,865
Smaller working-capital items
+€219,045
Receivables within one year
-€2.9m
Other debts
+€2.1m
Investment (derived)
-€114.5m
Investment in fixed assets (net)
-€82.9m
Current investments
-€31.6m
Financing
+€101.3m
Debts after one year
+€1.7m
Current portion of long-term debt
+€459
Short-term financial debts
-€125
Contributions, distributions and other
+€99.5m
Cash 2025
€836,424
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €54,302,920 | €172,147,434 | +€117.8m | +217% |
| Fixed assets | 21/28 | €51,855,306 | €134,658,875 | +€82.8m | +160% |
| Tangible fixed assets | 22/27 | €2,765,866 | €2,652,155 | -€113,710 | -4.1% |
| Land and buildings | 22 | €2,706,475 | €2,609,281 | -€97,194 | -3.6% |
| Plant, machinery and equipment | 23 | €40,205 | €29,778 | -€10,427 | -25.9% |
| Furniture and vehicles | 24 | €19,186 | €13,096 | -€6,089 | -31.7% |
| Assets under construction and advance payments | 27 | €0 | - | = | |
| Financial fixed assets | 28 | €49,089,440 | €132,006,719 | +€82.9m | +169% |
| Current assets | 29/58 | €2,447,615 | €37,488,559 | +€35.0m | +1,432% |
| Stocks and contracts in progress | 3 | €270,457 | €244,456 | -€26,001 | -9.6% |
| Stocks | 30/36 | €270,457 | €244,456 | -€26,001 | -9.6% |
| Amounts receivable within one year | 40/41 | €1,390,747 | €4,267,089 | +€2.9m | +207% |
| Trade receivables | 40 | €91,395 | €109,019 | +€17,624 | +19.3% |
| Other amounts receivable | 41 | €1,299,352 | €4,158,069 | +€2.9m | +220% |
| Current investments | 50/53 | €510,561 | €32,129,620 | +€31.6m | +6,193% |
| Cash at bank and in hand | 54/58 | €271,914 | €836,424 | +€564,510 | +208% |
| Deferred charges and accrued income | 490/1 | €3,935 | €10,971 | +€7,036 | +179% |
| Total equity and liabilities | 10/49 | €54,302,920 | €172,147,434 | +€117.8m | +217% |
| Equity | 10/15 | €53,490,368 | €167,332,901 | +€113.8m | +213% |
| Contributions | 10/11 | €16,550,000 | €52,796,682 | +€36.2m | +219% |
| Capital | 10 | €16,550,000 | €52,796,682 | +€36.2m | +219% |
| Issued capital | 100 | €16,550,000 | €52,796,682 | +€36.2m | +219% |
| Reserves | 13 | €35,129,750 | €112,725,601 | +€77.6m | +221% |
| Non-distributable reserves | 130/1 | €1,655,000 | €2,376,122 | +€721,122 | +43.6% |
| Legal reserve | 130 | €1,655,000 | €2,376,122 | +€721,122 | +43.6% |
| Tax-exempt reserves | 132 | €23,750 | €23,750 | = | 0.0% |
| Distributable reserves | 133 | €33,451,000 | €110,325,729 | +€76.9m | +230% |
| Profit (loss) carried forward | 14 | €1,810,618 | €1,810,618 | = | 0.0% |
| Amounts payable | 17/49 | €812,553 | €4,814,533 | +€4.0m | +493% |
| Amounts payable after more than one year | 17 | €306,057 | €2,021,045 | +€1.7m | +560% |
| Financial debts | 170/4 | €306,057 | €2,021,045 | +€1.7m | +560% |
| Amounts payable within one year | 42/48 | €494,248 | €2,622,629 | +€2.1m | +431% |
| Current portion of amounts payable after more than one year | 42 | €34,906 | €35,365 | +€459 | +1.3% |
| Financial debts | 43 | €137 | €12 | -€125 | -91.3% |
| Credit institutions | 430/8 | €137 | €12 | -€125 | -91.3% |
| Trade debts | 44 | €105,630 | €149,314 | +€43,684 | +41.4% |
| Suppliers | 440/4 | €105,630 | €149,314 | +€43,684 | +41.4% |
| Taxes, remuneration and social security | 45 | €223,848 | €221,632 | -€2,216 | -1.0% |
| Taxes | 450/3 | €208,049 | €213,577 | +€5,528 | +2.7% |
| Remuneration and social security | 454/9 | €15,800 | €8,055 | -€7,745 | -49.0% |
| Other amounts payable | 47/48 | €129,727 | €2,216,305 | +€2.1m | +1,608% |
| Accrued charges and deferred income | 492/3 | €12,248 | €170,860 | +€158,612 | +1,295% |
| Non-recurring operating income | 76A | €8,403 | €0 | -€8,403 | -100% |
| Remuneration, social security and pensions | 62 | €145,397 | €117,649 | -€27,747 | -19.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €114,577 | €120,865 | +€6,288 | +5.5% |
| Other operating charges | 640/8 | €1,788 | €43,174 | +€41,385 | +2,314% |
| Gross operating margin | 9900 | €324,951 | €113,036 | -€211,915 | -65.2% |
| Operating profit (loss) | 9901 | €63,188 | -€168,652 | -€231,841 | |
| Financial income | 75/76B | €1,019,786 | €15,878,369 | +€14.9m | +1,457% |
| Recurring financial income | 75 | €1,019,786 | €14,929,607 | +€13.9m | +1,364% |
| Non-recurring financial income | 76B | - | €948,762 | +€948,762 | |
| Financial charges | 65/66B | €20,857 | €1,228,303 | +€1.2m | +5,789% |
| Recurring financial charges | 65 | €20,857 | €790,860 | +€770,004 | +3,692% |
| Non-recurring financial charges | 66B | - | €437,442 | +€437,442 | |
| Profit (loss) for the period before taxes | 9903 | €1,062,118 | €14,481,414 | +€13.4m | +1,263% |
| Income taxes | 67/77 | €96,837 | €184,975 | +€88,138 | +91.0% |
| Profit (loss) for the period | 9904 | €965,281 | €14,296,439 | +€13.3m | +1,381% |
| Profit (loss) for the period to be appropriated | 9905 | €965,281 | €14,296,439 | +€13.3m | +1,381% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.